BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Treatment
1669 results:

  • 1. On the mechanism of wogonin against acute monocytic leukemia using network pharmacology and experimental validation.
    Wang X; Wang Y; Chen J; Wang Q; Liu Z; Yin Y; Yang T; Shen T; Sa Y
    Sci Rep; 2024 May; 14(1):10114. PubMed ID: 38698063
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Regulation of Hypoxia Dependent Reprogramming of Cancer Metabolism: Role of HIF-1 and Its Potential Therapeutic Implications in leukemia.
    Pandey S; Singh R; Habib N; Tripathi RM; Kushwaha R; Mahdi AA
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1121-1134. PubMed ID: 38679971
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ONC212 enhances YM155 cytotoxicity by triggering SLC35F2 expression and NOXA-dependent MCL1 degradation in acute myeloid leukemia cells.
    Chiou JT; Chang LS
    Biochem Pharmacol; 2024 Jun; 224():116242. PubMed ID: 38679209
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Effect of Shikonin on Autophagy and Apoptosis of Human Promyelocytic leukemia Cells].
    Chen Y; Xie XM; Zhang XL; Zhang XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):416-421. PubMed ID: 38660845
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid leukemia.
    Jebanesan DZP; Illangeswaran RSS; Rajamani BM; Vidhyadharan RT; Das S; Bijukumar NK; Balakrishnan B; Mathews V; Velayudhan SR; Balasubramanian P
    Ann Hematol; 2024 Jun; 103(6):1919-1929. PubMed ID: 38630133
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Novel PIKfyve/Tubulin Dual-target Inhibitor as a Promising Therapeutic Strategy for B-cell Acute Lymphoblastic leukemia.
    Lu Z; Lai Q; Li ZF; Zhong MY; Jiang YL; Feng LY; Zha J; Yao JW; Li Y; Deng XM; Xu B
    Curr Med Sci; 2024 Apr; 44(2):298-308. PubMed ID: 38619682
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A prognostic model of idiopathic pulmonary fibrosis constructed based on macrophage and mitochondria-related genes.
    Bao Y; Yang S; Zhao H; Wang Y; Li K; Liu X; Zhang W; Zhu X
    BMC Pulm Med; 2024 Apr; 24(1):176. PubMed ID: 38609879
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Discovery of Potent and Selective PI3Kδ Inhibitors for the treatment of Acute Myeloid leukemia.
    Tang Y; Zheng Y; Hu X; Zhao H; Cui S
    J Med Chem; 2024 Apr; 67(8):6638-6657. PubMed ID: 38577724
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. PHA-665752's Antigrowth and Proapoptotic Effects on HSC-3 Human Oral Cancer Cells.
    Yadav AK; Wang S; Shin YM; Jang BC
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474118
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Inhibition of PRMT5/MEP50 Arginine Methyltransferase Activity Causes Cancer Vulnerability in NDRG2
    Ichikawa T; Suekane A; Nakahata S; Iha H; Shimoda K; Murakami T; Morishita K
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474089
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Anlotinib Inhibits Cisplatin Resistance in Non-Small-Cell Lung Cancer Cells by Inhibiting MCL-1 Expression via MET/STAT3/akt Pathway.
    Wang L; Xu L; Han S; Zhu X
    Can Respir J; 2024; 2024():2632014. PubMed ID: 38468814
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Gene expression profiling on CML patients with Philadelphia translocation.
    Alkhatabi H; Aldahlawi S; Hazzazi MS; Alsolami R; Elaimi A; Almashjary MN; Alserihi R; Alkhatabi HA; Alquthami ME; Daous YM; Bahashwan S; Yasin EB; Barefah A; Alsayes F
    Eur Rev Med Pharmacol Sci; 2024 Feb; 28(4):1340-1355. PubMed ID: 38436167
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [MiR-217 Targeting PI3K/akt Pathway Enhances Sensitivity of Adriamycin to Acute Myeloid leukemia].
    Gan DY; Wu J; Zhou M; Chen W; Jiang W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):39-44. PubMed ID: 38387897
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A molecular circuit linking the BCR to the NAD biosynthetic enzyme NAMPT is an actionable target in Richter syndrome.
    Messana VG; Fascì A; Vitale N; Micillo M; Rovere M; Pesce NA; Martines C; Efremov DG; Vaisitti T; Deaglio S
    Blood Adv; 2024 Apr; 8(8):1920-1933. PubMed ID: 38359376
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Licochalcone A induces mitochondria-dependent apoptosis and interacts with venetoclax in acute myeloid leukemia.
    Li Y; Zhao M; Lin Y; Jiang X; Jin L; Ye P; Lu Y; Pei R; Jiang L
    Eur J Pharmacol; 2024 Apr; 968():176418. PubMed ID: 38350590
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. IDH2/R140Q mutation confers cytokine-independent proliferation of TF-1 cells by activating constitutive STAT3/5 phosphorylation.
    Yang J; Chen J; Chang J; Sun X; Wei Q; Cai X; Cao P
    Cell Commun Signal; 2024 Feb; 22(1):116. PubMed ID: 38347540
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. SHP-1 inhibition targets leukaemia stem cells to restore immunosurveillance and enhance chemosensitivity by metabolic reprogramming.
    Xu X; Yu Y; Zhang W; Ma W; He C; Qiu G; Wang X; Liu Q; Zhao M; Xie J; Tao F; Perry JM; Liu Q; Rao S; Kang X; Zhao M; Jiang L
    Nat Cell Biol; 2024 Mar; 26(3):464-477. PubMed ID: 38321204
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Bioactive triterpenoid compounds of Poria cocos (Schw.) Wolf in the treatment of diabetic ulcers via regulating the PI3K-akt signaling pathway.
    Ding X; Li S; Huang H; Shen J; Ding Y; Chen T; Ma L; Liu J; Lai Y; Chen B; Wang Y; Tan Q
    J Ethnopharmacol; 2024 May; 325():117812. PubMed ID: 38301984
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Carbapenem-resistant Klebsiella pneumoniae bloodstream infections in haematological malignances and hematopoietic stem cell transplantation: Clinical impact of combination therapy in a 10-year Brazilian cohort.
    de Souza ILA; Cappellano P; Ferreira DB; Bergamasco MD; das Chagas Neto TC; Kerbauy FR; Baiocchi OCG; Pignatari ACC
    PLoS One; 2024; 19(1):e0297161. PubMed ID: 38277372
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Long non-coding RNA small nucleolar RNA host gene 29 drives chronic myeloid leukemia progression via microRNA-483-3p/Casitas B-lineage Lymphoma axis-mediated activation of the phosphoinositide 3-kinase/akt pathway.
    Feng X; Yang L; Liu X; Liu M; Liu L; Liu J; Luo J
    Med Oncol; 2024 Jan; 41(2):60. PubMed ID: 38252204
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 84.